Outcome of the Meeting of Preferential Issue Committee of the Board of Directors of Medicamen Biotech Limited…
As filed · Medicamen Biotech Limited has informed the Exchange regarding 'Outcome of the Meeting of Preferential Issue Committee of the Board of Directors of Medicamen Biotech Limited ( the Company ) in accordan
What happened
FactOutcome of the Meeting of Preferential Issue Committee of the Board of Directors of Medicamen Biotech Limited ( the Company ) in accordance with Regulation 30 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.'. Conversion of 5,00,000 Fully Convertible Warrants (“Warrants”) at an issue price of Rs. 530/- per equity share. The meeting of Preferential Issue Committee of the Board of Directors commenced at 11.00 AM…
Why it matters
CapitSignal interpretationShares are issued to named investors at a set price, diluting existing holders and changing who sits on the register.
Watch next
Fact- Who the allottees are
- Issue price versus market price
- Lock-in period on the new shares
Evidence
How CapitSignal classified this
- Reasoning:
- PREFERENTIAL_ALLOTMENT base 66; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%